Luke Walker - Jun 12, 2025 Form 4 Insider Report for Context Therapeutics Inc. (CNTX)

Role
Director
Signature
/s/ Alex Levit, Attorney-in-Fact
Stock symbol
CNTX
Transactions as of
Jun 12, 2025
Transactions value $
$0
Form type
4
Date filed
6/12/2025, 05:24 PM
Previous filing
Feb 4, 2025
Next filing
Jun 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Walker Luke Nathaniel Director 2001 MARKET STREET, SUITE 3915 UNIT #15, PHILADELPHIA /s/ Alex Levit, Attorney-in-Fact 2025-06-12 0001701440

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNTX Stock Option (right to buy) Award $0 +124K $0.00 124K Jun 12, 2025 Common Stock 124K $0.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable on the earlier of (i) June 12, 2026 (the one-year anniversary of the date of grant) or (ii) the Issuer's 2026 annual meeting of stockholders, subject to continued service with the Issuer.